{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:59:53Z","timestamp":1791086393894,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1093\/ageing\/afi219","type":"journal-article","created":{"date-parts":[[2005,12,19]],"date-time":"2005-12-19T08:47:52Z","timestamp":1134982072000},"page":"60-65","source":"Crossref","is-referenced-by-count":41,"title":["Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels"],"prefix":"10.1093","volume":"35","author":[{"given":"Roberto Antonio","family":"Mangiafico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Sarnataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mangiafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo Erio","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1]]},"reference":[{"key":"key\n\t\t\t\t20171010143519_","unstructured":"Only the most important references are listed here and are represented by bold type throughout the text. The full list of references is available as supplementary data on the journal website (www.ageing.oxfordjournals.org)."},{"key":"key\n\t\t\t\t20171010143519_BIB1","doi-asserted-by":"crossref","unstructured":"Leng GC , Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ1996; 313: 1440\u20134.","DOI":"10.1136\/bmj.313.7070.1440"},{"key":"key\n\t\t\t\t20171010143519_BIB3","doi-asserted-by":"crossref","unstructured":"Stoffers HE , Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol1996; 25:282\u201390.","DOI":"10.1093\/ije\/25.2.282"},{"key":"key\n\t\t\t\t20171010143519_BIB7","doi-asserted-by":"crossref","unstructured":"Phillips NA , Mate-Kole CC. Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects. Stroke1997; 28: 777\u201384.","DOI":"10.1161\/01.STR.28.4.777"},{"key":"key\n\t\t\t\t20171010143519_BIB8","doi-asserted-by":"crossref","unstructured":"Waldstein SR , Tankard CF, Maier KJ et al. Peripheral arterial disease and cognitive function. Psychosom Med2003; 65: 757\u201363.","DOI":"10.1097\/01.PSY.0000088581.09495.5E"},{"key":"key\n\t\t\t\t20171010143519_BIB9","doi-asserted-by":"crossref","unstructured":"Rao R , Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease. A comparison with healthy community residents. Stroke1999; 30: 2167\u201373.","DOI":"10.1161\/01.STR.30.10.2167"},{"key":"key\n\t\t\t\t20171010143519_BIB10","doi-asserted-by":"crossref","unstructured":"Elwood PC , Pickering J, Bayer A, Gallacher JE. Vascular disease and cognitive function in older men in the Caerphilly cohort. Age Ageing2002; 31:43\u20138.","DOI":"10.1093\/ageing\/31.1.43"},{"key":"key\n\t\t\t\t20171010143519_BIB11","doi-asserted-by":"crossref","unstructured":"Singh-Manoux A , Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc2003; 51: 1445\u201350.","DOI":"10.1046\/j.1532-5415.2003.51464.x"},{"key":"key\n\t\t\t\t20171010143519_BIB12","doi-asserted-by":"crossref","unstructured":"Heinrich J , Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost1995; 73: 374\u20139.","DOI":"10.1055\/s-0038-1653783"},{"key":"key\n\t\t\t\t20171010143519_BIB20","doi-asserted-by":"crossref","unstructured":"Yaffe K , Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology2003; 61:76\u201380.","DOI":"10.1212\/01.WNL.0000073620.42047.D7"},{"key":"key\n\t\t\t\t20171010143519_BIB22","doi-asserted-by":"crossref","unstructured":"Wilson CJ , Cohen HJ, Pieper CF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc2003; 51:1374\u201381.","DOI":"10.1046\/j.1532-5415.2003.51454.x"},{"key":"key\n\t\t\t\t20171010143519_BIB24","doi-asserted-by":"crossref","unstructured":"Cerhan JR , Folsom AR, Mortimer JA et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology1998; 44: 95\u2013105.","DOI":"10.1159\/000021991"},{"key":"key\n\t\t\t\t20171010143519_BIB28","doi-asserted-by":"crossref","unstructured":"Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol1988; 17: 248\u201354.","DOI":"10.1093\/ije\/17.2.248"},{"key":"key\n\t\t\t\t20171010143519_BIB30","unstructured":"Wechsler D. Wechsler Adult Intelligence Scale, Revised. New York, NY: Psychological Corporation,1981."},{"key":"key\n\t\t\t\t20171010143519_BIB31","unstructured":"Reitan RM , Davison LA. Clinical neuropsychology: current status and applications. New York, NY: Wiley,1974."},{"key":"key\n\t\t\t\t20171010143519_BIB32","unstructured":"Rey A. L\u2019examen psychologique dans les cas d\u2019enc\u00e9phalopathie traumatique. Arch Psychol1941; 28: 286\u2013340."},{"key":"key\n\t\t\t\t20171010143519_BIB33","unstructured":"Osterrieth PA. Le test de copie d\u2019une figure complexe. Arch Psychol1944; 30:206\u2013356."},{"key":"key\n\t\t\t\t20171010143519_BIB36","doi-asserted-by":"crossref","unstructured":"Bots ML , van Swieten JC, Breteler MM et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet1993; 341: 1232\u201337.","DOI":"10.1016\/0140-6736(93)91144-B"},{"key":"key\n\t\t\t\t20171010143519_BIB37","doi-asserted-by":"crossref","unstructured":"Jorgensen HS , Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke1994; 25:97\u2013104.","DOI":"10.1161\/01.STR.25.1.97"},{"key":"key\n\t\t\t\t20171010143519_BIB38","doi-asserted-by":"crossref","unstructured":"Swan GE , DeCarli C, Miller BL, Reed T, Wolf PA, Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology2000; 54: 2108\u201314.","DOI":"10.1212\/WNL.54.11.2108"},{"key":"key\n\t\t\t\t20171010143519_BIB39","doi-asserted-by":"crossref","unstructured":"Vermeer SE , Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med2003; 348: 1215\u201322.","DOI":"10.1056\/NEJMoa022066"},{"key":"key\n\t\t\t\t20171010143519_BIB40","doi-asserted-by":"crossref","unstructured":"de Groot JC , de Leeuw FE, Oudkerk M et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol2000; 47:145\u201351.","DOI":"10.1002\/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P"},{"key":"key\n\t\t\t\t20171010143519_BIB41","doi-asserted-by":"crossref","unstructured":"Breteler MM. Vascular risk factors for Alzheimer\u2019s disease: an epidemiologic perspective. Neurobiol Aging2000; 21:153\u201360.","DOI":"10.1016\/S0197-4580(99)00110-4"},{"key":"key\n\t\t\t\t20171010143519_BIB43","doi-asserted-by":"crossref","unstructured":"Lindsberg PJ , Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke2003; 34: 2518\u201332.","DOI":"10.1161\/01.STR.0000089015.51603.CC"},{"key":"key\n\t\t\t\t20171010143519_BIB44","doi-asserted-by":"crossref","unstructured":"Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci1982; 389:235\u201350.","DOI":"10.1111\/j.1749-6632.1982.tb22140.x"},{"key":"key\n\t\t\t\t20171010143519_BIB45","doi-asserted-by":"crossref","unstructured":"Galve-de Rochemonteix B , Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol1993; 53: 439\u201345.","DOI":"10.1002\/jlb.53.4.439"},{"key":"key\n\t\t\t\t20171010143519_BIB46","doi-asserted-by":"crossref","unstructured":"Cermak J , Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood1993; 82:513\u201320.","DOI":"10.1182\/blood.V82.2.513.bloodjournal822513"},{"key":"key\n\t\t\t\t20171010143519_BIB47","doi-asserted-by":"crossref","unstructured":"Kario K , Matsuo T, Hoshide S, Umeda Y, Shimada K. Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke1999; 30:1033\u20137.","DOI":"10.1161\/01.STR.30.5.1033"},{"key":"key\n\t\t\t\t20171010143519_BIB48","doi-asserted-by":"crossref","unstructured":"Robson SC , Shephard EG, Kirsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol1994; 86: 322\u20136.","DOI":"10.1111\/j.1365-2141.1994.tb04733.x"},{"key":"key\n\t\t\t\t20171010143519_BIB51","unstructured":"Phillips NA. Thinking on your feet: a neuropsychological review of peripheral arterial disease. In Waldstein SR, Elias MF, eds. Neuropsychology of Cardiovascular Disease. Mahwah, NJ: Lawrence Erlbaum Associates, 2001 pp. 121\u201342."},{"key":"key\n\t\t\t\t20171010143519_BIB52","doi-asserted-by":"crossref","unstructured":"Ingles JL , Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke2002; 33:1999\u20132002.","DOI":"10.1161\/01.STR.0000024433.36590.1B"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ageing\/article-pdf\/35\/1\/60\/73349\/afi219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T17:05:06Z","timestamp":1586624706000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ageing\/article\/35\/1\/60\/33440\/Impaired-cognitive-performance-in-asymptomatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,1]]},"published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afi219","relation":{},"ISSN":["1468-2834","0002-0729"],"issn-type":[{"value":"1468-2834","type":"electronic"},{"value":"0002-0729","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,1]]},"published":{"date-parts":[[2006,1,1]]}}}